Meeting the Standards of Normal Science in Health Outcomes and Market ccess
Meeting the Standards of Normal Science in Health Outcomes and Market ccess
Meeting the Standards of Normal Science in Health Outcomes and Market Access for Pharmaceutical Products and Devices
Meeting the Standards of Normal Science in Health Outcomes and Market Access for Pharmaceutical Products and Devices

Publications

P C Langley, Health Economics in the Drug Life Cycle, London: Urch Publishing, November 2002 (135 pp.)

 

P C Langley, The importance of health economics in successfully achieving a sustainable price for reimbursement, The Pharmaceutical Pricing Compendium, pp. 49-60 (London: Urch Publishing, 2003).

 

P C Langley, D White, S Drake, Patterns of Treatment and Resource Utilization in the Treatment of External Genital Warts in England and Wales: The Results of a Clinical Audit, International Journal of STD and AIDS, 2004; 15: 473-468.

 

P C Langley, Focusing Pharmacoeconomic Activities: Reimbursement or the drug life cycle, Current Medical Research and Opinion, 2004; 20(2): 181-188.

 

P C Langley, The NICE Reference Case Requirement: Implications for Manufacturers and Health Systems, Pharmacoeconomics, 2004; 22(4): 267-271.

 

P C Langley. Patkar AD, Boswell KA, Benson CJ, Schein JR. Adverse event profile of tramadol in recent clinical studies of chronic osteoarthritis pain. Curr Med Res Opin. 2010;26(1):239-51.

 

P C Langley, Muller-Schwefe G, Nicolaou A et al. The societal impact of pain in the European Union: health-related quality of life and healthcare resource utilization. J Med Econ. 2010;13(2):571-81.

 

P C Langley, Muller-Schwefe G, Nicolaou A et al. The impact of pain on labor force participation, absenteeism and presenteeism in the European Union. J Med Econ. 2010;13(4):662-72.

 

P C Langley. The prevalence, correlates and treatment of pain in the European Union. Curr Med Res Opin. 2011 Feb;27(2):463-80.

P C Langley, Tornero Molina J, Margarit Ferri C, et al. The association of pain with labor force participation, absenteeism and presenteeism in Spain. J Med Econ. 2011;14(6):835-45 

 

P C Langley. The societal burden of pain in Germany: Health related quality of life, health status and direct medical costs. J Med Econ. 2012;15(6):1201-15.

 

P C Langley, Van Litsenburg C, Cappelleri J et al. The burden associated with neuropathic pain in Western Europe. J Med Econ. 2013;16(1):85-95.

 

P C Langley, Liedgens H. Time since diagnosis, treatment pathways and current pain status: a retrospective assessment in a back pain population. J Med Econ. 2013;16(5):701-9

 

Langley P. The status of modeled claims. J Med Econ 2015;18(12):991-992

Langley P. Validation of modeled pharmacoeconomic claims in formulary submissions. J Med Econ 2015;18(12):993-999

Print Print | Sitemap
© Maimon Research LLC